132 related articles for article (PubMed ID: 9795471)
21. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
22. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Rosengren H; Polson RJ
Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
[TBL] [Abstract][Full Text] [Related]
23. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
[TBL] [Abstract][Full Text] [Related]
24. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
25. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
26. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
27. Economic evaluation in gastrointestinal disease.
Jönsson B; Karlsson G
Scand J Gastroenterol Suppl; 1996; 220():44-51. PubMed ID: 8898435
[TBL] [Abstract][Full Text] [Related]
28. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Multiple Center Study Group In Beijing Area, China
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976
[TBL] [Abstract][Full Text] [Related]
29. [GERD after H. pylori eradication therapy].
Kinoshita Y; Adachi K; Ishihara S
Nihon Rinsho; 2002 Feb; 60 Suppl 2():477-82. PubMed ID: 11979831
[No Abstract] [Full Text] [Related]
30. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
[TBL] [Abstract][Full Text] [Related]
31. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis.
Koike T; Ohara S; Sekine H; Iijima K; Kato K; Toyota T; Shimosegawa T
Aliment Pharmacol Ther; 2001 Jun; 15(6):813-20. PubMed ID: 11380319
[TBL] [Abstract][Full Text] [Related]
32. [Occurrence of upper gastrointestinal tract disease after Helicobacter pylori eradication].
Kodama M; Fujioka T; Murakami K; Sato R
Nihon Rinsho; 2001 Feb; 59(2):333-6. PubMed ID: 11218408
[TBL] [Abstract][Full Text] [Related]
33. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
34. Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
Plein K; Madisch A; Stolte M; Hotz J
Z Gastroenterol; 2001 Jul; 39(7):503-10. PubMed ID: 11505330
[TBL] [Abstract][Full Text] [Related]
35. [Occurrence of upper gastrointestinal tract disease after Helicobacter pylori eradication].
Kodama M; Nomura N; Kagawa J; Fujioka T; Murakami K; Sato R
Nihon Rinsho; 2002 Aug; 60(8):1639-43. PubMed ID: 12187764
[TBL] [Abstract][Full Text] [Related]
36. The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease.
Tan J; Wang Y; Sun X; Cui W; Ge J; Lin L
Am J Med Sci; 2015 Apr; 349(4):364-71. PubMed ID: 25767896
[TBL] [Abstract][Full Text] [Related]
37. [Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease].
Gisbert JP; Piqué JM
Med Clin (Barc); 2005 May; 124(18):697-709. PubMed ID: 15899166
[TBL] [Abstract][Full Text] [Related]
38. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.
Laine L; Sugg J
Am J Gastroenterol; 2002 Dec; 97(12):2992-7. PubMed ID: 12492181
[TBL] [Abstract][Full Text] [Related]
39. Motion--Helicobacter pylori worsens GERD: arguments for the motion.
O'Morain CA; Qasim A
Can J Gastroenterol; 2002 Sep; 16(9):611-4. PubMed ID: 12362215
[TBL] [Abstract][Full Text] [Related]
40. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.
van Grieken NC; Meijer GA; Weiss MM; Bloemena E; Lindeman J; Baak JP; Meuwissen SG; Kuipers EJ
Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
